Sanofi’s dupixent approved in the US as the first-ever biologic medicine for patients with COPD
Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an eosinophilic phenotype
Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an eosinophilic phenotype
The Notes shall not be offered or sold in India
This initiative aims to raise awareness about the importance of monitoring blood sugar levels before indulging in sweets
The objectives of the campaign are to raise awareness about glaucoma, its risk factors, and the importance of regular eye check-up
This office will be the central hub for all operations related to companies ethical pharmaceutical business
This approval reflects company’s unwavering commitment that the quality assurance
Based out of Boston, Vivek will build on the foundation created by Vaidheesh, and will help build a stronger customer connect and further drive global expansion of the platform
A multi-disciplinary team of senior physicians opted to use Zidebactam/Cefepime under compassionate use
Fermenta Biotech’s API manufacturing facility receives EU GMP compliance certificate
This license will enable Abbott to enhance access to this novel therapy to more patients across India
Subscribe To Our Newsletter & Stay Updated